How This Biotech Could Dethrone Oxycodone In Treating Pain – Investor’s Business Daily


Investor's Business Daily

How This Biotech Could Dethrone Oxycodone In Treating Pain
Investor's Business Daily
Nektar Therapeutics (NKTR) stock popped to a three-month high Tuesday after the biotech said its chronic pain drug, NKTR-181, showed significantly less abuse potential compared with an oft-abused opioid. On the stock market today, Nektar stock lifted ...

and more »

Read More

How This Biotech Could Dethrone Oxycodone In Treating Pain – Investor’s Business Daily


Investor's Business Daily

How This Biotech Could Dethrone Oxycodone In Treating Pain
Investor's Business Daily
Nektar Therapeutics (NKTR) stock popped to a three-month high Tuesday after the biotech said its chronic pain drug, NKTR-181, showed significantly less abuse potential compared with an oft-abused opioid. On the stock market today, Nektar stock lifted ...

and more »

Read More

How This Biotech Could Dethrone Oxycodone In Treating Pain – Investor’s Business Daily


Investor's Business Daily

How This Biotech Could Dethrone Oxycodone In Treating Pain
Investor's Business Daily
Nektar Therapeutics (NKTR) stock popped to a three-month high Tuesday after the biotech said its chronic pain drug, NKTR-181, showed significantly less abuse potential compared with an oft-abused opioid. On the stock market today, Nektar stock lifted ...

and more »

Read More